The survey of the effect of adding aspirin to anti-migraine drugs on the severity of the headache in patients with chronic migraine headaches with lateral venous sinus stenosis in MRV

Phase 3

• Conditions: Patients with chronic headache (by definition) known as migraine (according to the IHS diagnostic criteria); Aspirin; Migraine Disorders; Headache; Vascular Malformations; Brain

• Registration Number: TCTR20210427007
• Lead Sponsor: Artesh University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-04-27
• Study Completion: 2021-05-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with chronic headache (by definition) known as migraine (according to the IHS diagnostic criteria)
Patients who have had brain lateral venous sinus stenosis in MRV according to a report by a radiologist and confirmed by a neurologist (Interventional Fellowship)

Exclusion Criteria

Patients with headache who did not meet the criteria for chronic headache
Patients with MRV who have evidence in favor of other brain lesions such as tumors or vascular malformations
Patients with a history of vascular disease or Brain space lesions
Contraindications to aspirin use (aspirin allergy, history of peptic ulcer, history of asthma)
The patient's unwillingness to cooperate or continue the plan
Pregnancy, breastfeeding

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
severity of migraine Before the intervention, 1 months after the intervention Visual Analogue Pain Scale (VAS)

Secondary Outcome Measures

Name	Time	Method
Severity of headache, duration of headache, number of headaches Before intervention, 1 months after intervention Visual Analogue Scale(VAS)